Simplify Logo

Full-Time

Patient & Community Educator – Lead

Confirmed live in the last 24 hours

Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

501-1,000 employees

Develops therapies for neurological disorders

Biotechnology
Healthcare

Compensation Overview

$168k - $210kAnnually

+ Bonus + Equity Awards

Senior, Expert

Remote in USA

Category
Healthcare Administration & Support
Nursing & Allied Health Professionals
Medical, Clinical & Veterinary
Required Skills
Sales
Communications
Marketing
Requirements
  • Bachelor of Science in healthcare field strongly preferred with a minimum of 10 years’ experience in a similar role within the pharmaceutical/biotech industry.
  • Customer-facing or field leadership experience (required).
  • Experience leading a team to achieve organizational goals.
  • Patient-centric mentality with high emotional intelligence and empathy.
  • Understanding of HIPAA rules and regulations related to patient privacy.
  • Strong written and verbal communication, presentation skills, and comfort around senior/executive leadership.
  • Demonstrated history of successful cross-functional collaboration.
  • Strong leadership skills, ability to perform in fast-paced environments, and influence without authority.
  • Ability to present ideas effectively to various audiences.
  • Highly motivated, detail-oriented, and able to work under tight timelines and changing situations.
  • Excellent problem-solving skills and interpersonal flexibility.
Responsibilities
  • Lead and manage a team of 6, Patient & Community Educators (PACE) to deliver disease and product education to caregivers.
  • Develop and execute strategic and tactical plans for the PACE team to educate patients and their families/caregivers.
  • Collaborate with Marketing, Field Sales, Patient Services Hub, Medical Affairs, Advocacy, and other critical functions to establish success factors and objectives.
  • Identify, develop, and lead strategic partnerships with relevant external organizations for insight generation and educational outreach.
  • Hire, onboard, and sustain a high-performing, diverse team, and develop ongoing training plans.
  • Establish targeted work plans for regional team members.
  • Develop KPIs and reporting dashboards to track critical business metrics.
  • Provide constructive feedback on existing work plans and propose innovative service offerings.
  • Participate in the development of materials to increase provider and patient/caregiver awareness of educational services.
  • Contribute to the annual business/brand planning process with Marketing and leadership.
  • Represent the PACE team on various cross-functional teams.
  • Oversee team performance management, including coaching, training, development, and evaluation.
Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. Their products are created through extensive research and development, followed by rigorous clinical trials to ensure safety and effectiveness. Once approved by regulatory bodies like the FDA, these therapies are marketed to patients and healthcare providers. Acadia stands out from competitors by concentrating on areas with significant unmet medical needs and fostering strategic partnerships to enhance their research and market presence. The company's goal is to improve the quality of life for individuals with neurological conditions through effective treatments.

Company Stage

IPO

Total Funding

$813.4M

Headquarters

Dallas, Texas

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia's launch of Magnolia's Guide to Adventuring showcases their innovative approach to raising disease awareness and redefining perceptions of Rett syndrome.
  • The acceptance of trofinetide for priority review by Health Canada could lead to significant market expansion and first-mover advantage in treating Rett syndrome in Canada.
  • The appointment of Dr. Elizabeth H. Z. Thompson as Executive Vice President, Head of Research and Development, signals a strong commitment to advancing their R&D capabilities.

What critics are saying

  • The failure of the Phase III ADVANCE-2 trial for pimavanserin in schizophrenia highlights the high-risk nature of drug development in the biopharmaceutical sector.
  • Dependence on regulatory approvals, such as the FDA and Health Canada, introduces uncertainty and potential delays in bringing therapies to market.

What makes Acadia Pharmaceuticals Inc. unique

  • Acadia Pharmaceuticals focuses exclusively on neurological disorders, setting it apart from competitors with broader therapeutic areas.
  • Their commitment to corporate social responsibility, including initiatives like the Rett Sibling Scholarship, enhances their reputation and community engagement.
  • Acadia's strategic partnerships and corporate sponsorships amplify their research capabilities and market reach, distinguishing them from competitors who may not leverage such collaborations.